Pfizer Inc (PFE)

Days of sales outstanding (DSO)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Receivables turnover		—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
DSO	days	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

December 31, 2024 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —

Days Sales Outstanding (DSO) is a crucial financial metric that provides insights into how efficiently a company is managing its accounts receivable. It represents the average number of days it takes for a company to collect payment after making a sale.

Based on the data provided for Pfizer Inc, the DSO figures are not available for the period from March 31, 2020, to December 31, 2024. This lack of specific DSO values prevents us from performing a detailed analysis of Pfizer's accounts receivable management efficiency over this time frame.

In a typical analysis, a trend in DSO over time can indicate changes in the company's credit policies, collection effectiveness, or the quality of its customer base. A decreasing trend in DSO may suggest improvements in collections processes or more efficient credit terms, while an increasing trend could indicate potential issues with collections or credit risk.

Without the specific DSO values for Pfizer Inc, it is not possible to assess the company's effectiveness in managing its accounts receivable or to draw any conclusions regarding its financial performance based on this metric. Additional data or information would be necessary to perform a meaningful analysis of Pfizer's DSO and its implications for the company's overall financial health.